Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 1,085,480 |
|
|||||
| News | - | ||||||
| Day High | 0.0159 | Low High |
|||||
| Day Low | 0.0082 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| NovAccess Global Inc (QB) | XSNX | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0022 | 18.64% | 0.014 | 16:12:22 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.01155 | 0.0082 | 0.0159 | 0.014 | 0.0118 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 35 | 1,085,480 | $ 0.012836 | $ 13,933 | - | 0.0037 - 0.22 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:59:42 | 95,690 | $ 0.014 | USD |
NovAccess Global Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 276.74k | 21.44M | 4.76M | 0 | -4.77M | -0.17 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
NovAccess Global (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XSNX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.007 | 0.017 | 0.0037 | 0.0100063 | 820,689 | 0.007 | 100.00% |
| 1 Month | 0.0065 | 0.017 | 0.0037 | 0.006792 | 1,049,498 | 0.0075 | 115.38% |
| 3 Months | 0.0146 | 0.02615 | 0.0037 | 0.0092563 | 731,100 | -0.0006 | -4.11% |
| 6 Months | 0.036 | 0.054 | 0.0037 | 0.0136079 | 482,982 | -0.022 | -61.11% |
| 1 Year | 0.154 | 0.22 | 0.0037 | 0.0157088 | 272,031 | -0.14 | -90.91% |
| 3 Years | 0.48 | 0.97 | 0.0037 | 0.0358842 | 97,725 | -0.466 | -97.08% |
| 5 Years | 0.001 | 0.97 | 0.0002 | 0.0026757 | 1,137,311 | 0.013 | 1,300.00% |
NovAccess Global (QB) Description
| NovAccess Global Inc. is a biopharmaceutical company focused on the development and commercialization of novel immunotherapies to treat brain tumor patients in the United States with plans to expand globally. We are experts in cutting-edge research involving the use of a patient's own immune system to fight cancer. Through our advisory board we have experience successfully executing clinical trials, bringing products to market and increasing the market size of products. Our scientists are well versed in immunology, stem cell biology, neuroscience, molecular biology, imaging, small molecule development and gene therapy as well as other technical assays required for protein and genetic analysis of cancer cells. NovAccess Global is a research and development (R&D) company based in Ohio and California, and our executive management and scientific advisory board have over 15 years of experience in all aspects of biopharmaceutical R&D and commercialization of drug candidates. |
